The World Health Organization (WHO) has strongly recommended the drug baricitinib for patients with severe or critical COVID-19 in combination with corticosteroids. In the same guideline update, it also makes a conditional recommendation for the use of the monoclonal antibody sotrovimab in patients with non-severe disease, but only in those at the highest risk of hospitalization.
The World Health Organization has recommended the use of two new drugs for the treatment of Covid-19 patients. The recommendations were revealed on Friday in a peer-reviewed journal.